David Aviezer
2012
In 2012, David Aviezer earned a total compensation of $3.2M as President and Chief Executive Officer at Protalix BioTherapeutics, a 362% increase compared to previous year.
Compensation breakdown
| Bonus | $675,000 |
|---|---|
| Option Awards | $1,101,142 |
| Salary | $493,960 |
| Stock Awards | $860,963 |
| Other | $99,080 |
| Total | $3,230,145 |
Aviezer received $1.1M in option awards, accounting for 34% of the total pay in 2012.
Aviezer also received $675K in bonus, $494K in salary, $861K in stock awards and $99.1K in other compensation.
Rankings
In 2012, David Aviezer's compensation ranked 2,142nd out of 11,487 executives tracked by ExecPay. In other words, Aviezer earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,142 out of 11,487 | 81st |
Division Manufacturing | 754 out of 4,253 | 82nd |
Major group Chemicals And Allied Products | 169 out of 1,203 | 86th |
Industry group Drugs | 98 out of 925 | 89th |
Industry Biological Products, Except Diagnostic Substances | 17 out of 165 | 90th |
Source: SEC filing on October 9, 2014.
Aviezer's colleagues
We found four more compensation records of executives who worked with David Aviezer at Protalix BioTherapeutics in 2012.
2012
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2012
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2012
Yossi Maimon
Protalix BioTherapeutics
Chief Financial Officer
2012
Tzvi Palash
Protalix BioTherapeutics